Ann Ginsberg | Deputy Director, TB Vaccines
The Bill & Melinda Gates Foundation

Ann Ginsberg, Deputy Director, TB Vaccines, The Bill & Melinda Gates Foundation

Appearances:



Pre-congress Workshops, April 6 @ 10:00

WORKSHOP H (FULL DAY): ANTI MICROBIAL RESISTANCE

Harmonizing national and international priorities – what is the role of public health and government in implementation AMR efforts? Collaborative strategies from industry to halting the AMR crisis – do we have a consistent message? 10:00 Workshop leader opening remarks10:10 Vaccines as Another Strategy to Reduce Antibiotic Resistance in Healthcare Settings10:40 Gaps in veterinary vaccines to address AMR11:10 Why do we think this is possible? Update on vaccine technology that is enabling better vaccinesPipeline updates from biotech and industry – alternatives from antibiotics11:40 TB vaccines12:10 Bacterial Vaccine Polypeptides12:25 Vaccine efforts in Acinetobacter baumannii12:40 Update on the development of a Klebsiella and Pseudomonas vaccine
Moderator: George Siber, Chief Scientific Officer Of Clearpath Vaccines And Scientific Advisory Board Of Genocea, ClearPath Vaccines
Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK
Gregory Tobin, Chief Executive Officer, Biological Mimetics, Inc.
Ann Ginsberg, Deputy Director, TB Vaccines, The Bill & Melinda Gates Foundation
Shite Sebastian, Vice President, Affinivax
Anthony Fiore, Associate Director, Centers for Disease Control and Prevention
Terrence Stull, Senior Vice President Of Research, Phoenix Childrens Hospital
Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Plenary, April 7 @ 14:30

Global health challenges: How far are we from eliminating treatable infectious diseases?

  • Bridging multiple technologies for holistic treatment strategies
  • What have we learnt from HIV, TB, malaria, NTDs?
Dr Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children's Hospital Center, Baylor College of Medicine
Ann Ginsberg, Deputy Director, TB Vaccines, The Bill & Melinda Gates Foundation
Thomas Breuer, Senior Vice President, Chief Medical Officer, GSK Vaccines
Daria Hazuda, Vice President, Therapeutic Area, Head Of Infectious Disease And Chief Scientific Officer, Merck Research Laboratories
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates